NASDAQ:SNSE

Sensei Biotherapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy SNSE

*Your capital is at risk

$13.85

+0 (+0%)

At Close: Jul 31, 2026

Sensei Biotherapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 64.29. In total, the insiders bought 2.73M and sold 128.88K SNSE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	64.29
● Buy	2.73M shares
● Sell	128.88K shares
55% Buy Activity Negligible or No Correlation
Buy Signal Medium Confidence Feb 19, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 64.29. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 27, 2026 Sell	Common Stock S-Sale	Millennium Management Llc 10 Percent Owner	10% Owner	469 Value: $12.6K
Mar 27, 2026 Buy	Common Stock P-Purchase	Millennium Management Llc 10 Percent Owner	10% Owner	294 Value: $8K
Mar 27, 2026 Buy	Common Stock P-Purchase	Millennium Management Llc 10 Percent Owner	10% Owner	10 643 Value: $279.8K
Mar 27, 2026 Buy	Common Stock P-Purchase	Millennium Management Llc 10 Percent Owner	10% Owner	4 384 Value: $119.6K
Mar 26, 2026 Buy	Common Stock	Millennium Management Llc 10 Percent Owner	10% Owner	0 Value: $0
Mar 26, 2026 Sell	Common Stock S-Sale	Millennium Management Llc 10 Percent Owner	10% Owner	1 274 Value: $36.5K
Mar 26, 2026 Buy	Common Stock P-Purchase	Millennium Management Llc 10 Percent Owner	10% Owner	778 Value: $21.2K
Mar 26, 2026 Buy	Common Stock P-Purchase	Millennium Management Llc 10 Percent Owner	10% Owner	1 327 Value: $37.1K
Mar 26, 2026 Buy	Common Stock P-Purchase	Millennium Management Llc 10 Percent Owner	10% Owner	2 601 Value: $75.0K
Mar 26, 2026 Buy	Common Stock P-Purchase	Millennium Management Llc 10 Percent Owner	10% Owner	1 025 Value: $30.7K
Mar 26, 2026 Sell	Common Stock S-Sale	Millennium Management Llc 10 Percent Owner	10% Owner	583 Value: $15.7K
Feb 19, 2026 Buy	Employee Stock Option (right to buy) A-Award	Parikh Anand Kiran Chief Operating Officer	C-Suite Officer	1 239 305 Value: $33.7M
Feb 17, 2026 Buy	Common Stock J-Other	Parikh Anand Kiran Insider	Other	0 Value: $0
Feb 17, 2026 Buy	Employee Stock Option (right to buy) A-Award	Parikh Anand Kiran Chief Operating Officer	C-Suite Officer	56 673 Value: $65.7K
Feb 17, 2026 Buy	Series B Preferred Stock A-Award	Parikh Anand Kiran Chief Operating Officer	C-Suite Officer	809 822 Value: $7.60M
Feb 17, 2026 Buy	Employee Stock Option (right to buy) A-Award	Parikh Anand Kiran Chief Operating Officer	C-Suite Officer	92 533 Value: $107.3K
Feb 13, 2026 Buy	Common Stock J-Other	Donenberg Phillip B. Insider	Other	0 Value: $0
Feb 13, 2026 Buy	Stock Option (right to buy) A-Award	Donenberg Phillip B. Director	Director	1 900 Value: $17.3K
Dec 09, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Peyer James See Remarks Below	10% Owner	395 Value: $3K
Dec 09, 2025 Buy	Stock Option (Right to Buy) M-Exempt	Cambrian Biopharma Inc 10 Percent Owner	10% Owner	395 Value: $3K
Dec 09, 2025 Sell	Common Stock S-Sale	Cambrian Biopharma Inc 10 Percent Owner	10% Owner	446 Value: $4K
Dec 09, 2025 Sell	Common Stock S-Sale	Cambrian Biopharma Inc 10 Percent Owner	10% Owner	2 666 Value: $21.2K
Dec 09, 2025 Sell	Common Stock S-Sale	Cambrian Biopharma Inc 10 Percent Owner	10% Owner	3 105 Value: $26.7K
Dec 09, 2025 Buy	Common Stock M-Exempt	Peyer James See Remarks Below	10% Owner	395 Value: $3K
Dec 09, 2025 Sell	Common Stock S-Sale	Peyer James See Remarks Below	10% Owner	2 666 Value: $21.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SENSEI BIOTHERAPEUTICS, INC.

Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment Activated Biologics, a platform designed to unleash the anti-tumor po...

Read Full Profile Here